Challenges in the Diagnosis of Pituitary Neuroendocrine Tumors.
- Published in:
- Endocrine Pathology, 2021, v. 32, n. 2, p. 222, doi. 10.1007/s12022-021-09678-x
- By:
- Publication type:
- Article
Works matching IS 10463976 AND DT 2021 AND VI 32 AND IP 2
Results: 12
1
2
Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms.
- Published in:
- Endocrine Pathology, 2021, v. 32, n. 2, p. 245, doi. 10.1007/s12022-021-09676-z
- By:
- Publication type:
- Article
3
Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry.
- Published in:
- Endocrine Pathology, 2021, v. 32, n. 2, p. 228, doi. 10.1007/s12022-021-09675-0
- By:
- Publication type:
- Article
4
Neuroendocrine Tumors of the Thyroid and Their Mimics.
- Published in:
- Endocrine Pathology, 2021, v. 32, n. 2, p. 211, doi. 10.1007/s12022-021-09672-3
- By:
- Publication type:
- Article
5
Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms.
- Published in:
- Endocrine Pathology, 2021, v. 32, n. 2, p. 309, doi. 10.1007/s12022-020-09657-8
- By:
- Publication type:
- Article
6
Dopamine β-hydroxylase: An Essential and Optimal Immunohistochemical Marker for Pheochromocytoma and Sympathetic Paraganglioma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
7
Clinical Impact of Pathological Features Including the Ki-67 Labeling Index on Diagnosis and Prognosis of Adult and Pediatric Adrenocortical Tumors.
- Published in:
- Endocrine Pathology, 2021, v. 32, n. 2, p. 288, doi. 10.1007/s12022-020-09654-x
- By:
- Publication type:
- Article
8
The Association of Histologically Proven Chronic Lymphocytic Thyroiditis with Clinicopathological Features, Lymph Node Metastasis, and Recurrence Rates of Differentiated Thyroid Cancer.
- Published in:
- Endocrine Pathology, 2021, v. 32, n. 2, p. 280, doi. 10.1007/s12022-020-09653-y
- By:
- Publication type:
- Article
9
Overexpression of ODF1 in Gastrointestinal Tract Neuroendocrine Neoplasms: a Novel Potential Immunohistochemical Biomarker for Well-differentiated Neuroendocrine Tumors.
- Published in:
- Endocrine Pathology, 2021, v. 32, n. 2, p. 301, doi. 10.1007/s12022-020-09649-8
- By:
- Publication type:
- Article
10
Immunohistochemistry or Molecular Analysis: Which Method Is Better for Subtyping Craniopharyngioma?
- Published in:
- Endocrine Pathology, 2021, v. 32, n. 2, p. 262, doi. 10.1007/s12022-020-09644-z
- By:
- Publication type:
- Article
11
Impact of Molecular Testing on the Management of Indeterminate Thyroid Nodules Among Western and Asian Countries: a Systematic Review and Meta-analysis.
- Published in:
- Endocrine Pathology, 2021, v. 32, n. 2, p. 269, doi. 10.1007/s12022-020-09643-0
- By:
- Publication type:
- Article
12
Amyloid-Rich Pancreatic Neuroendocrine Tumors: a Potential Diagnostic Pitfall in Endoscopic Ultrasound–Guided Fine Needle Aspiration Cytology (EUS-FNAC).
- Published in:
- Endocrine Pathology, 2021, v. 32, n. 2, p. 318, doi. 10.1007/s12022-020-09625-2
- By:
- Publication type:
- Article